0001178913-18-001607.txt : 20180510
0001178913-18-001607.hdr.sgml : 20180510
20180510174042
ACCESSION NUMBER: 0001178913-18-001607
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180508
FILED AS OF DATE: 20180510
DATE AS OF CHANGE: 20180510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KAZANCHYAN ANNA
CENTRAL INDEX KEY: 0001369219
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36621
FILM NUMBER: 18824263
MAIL ADDRESS:
STREET 1: 933 MAMARONECK AVENUE
STREET 2: SUITE 103
CITY: MAMARONECK
STATE: NY
ZIP: 10543
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foamix Pharmaceuticals Ltd.
CENTRAL INDEX KEY: 0001606645
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 HOLZMAN ST.
STREET 2: WEIZMANN SCIENCE PARK
CITY: REHOVOT
STATE: L3
ZIP: 76704
BUSINESS PHONE: 97289316233
MAIL ADDRESS:
STREET 1: 2 HOLZMAN ST.
STREET 2: WEIZMANN SCIENCE PARK
CITY: REHOVOT
STATE: L3
ZIP: 76704
FORMER COMPANY:
FORMER CONFORMED NAME: Foamix Ltd.
DATE OF NAME CHANGE: 20140428
4
1
zk1821665.xml
OWNERSHIP DOCUMENT
X0306
4
2018-05-08
0
0001606645
Foamix Pharmaceuticals Ltd.
FOMX
0001369219
KAZANCHYAN ANNA
C/O FOAMIX PHARMACEUTICALS LTD.
2 HOLTZMAN STREET
REHOVOT
L3
7670402
ISRAEL
1
0
0
0
Ordinary Shares
2018-05-08
4
A
0
14829
0.00
A
27760
D
This security represents restricted share units. Each restricted share unit represents a contingent right to receive one ordinary share of the issuer.
The ordinary shares underlying this restricted share unit award vest over a period of three years from May 8, 2018 (33.3% on each anniversary of such date) and ending May 8, 2021.
The issuer's method of reporting restricted share units has been revised to report such grants in Table I rather than as previously reported in Table II. Accordingly, this amount includes (i) 12,931 ordinary shares subject to unvested restricted share units that were previously reported in Table II of the reporting person's Form 3 as a derivative security and ii) the 14,829 ordinary shares sub-ject to unvested restricted share units granted on May 8, 2018 and first reported on this Form 4.
/s/ _Ilan Hadar as attorney-in-fact for Anna Kazanchyan
2018-05-10